CAS 2212021-80-0
CAS 2212021-80-0
Purity:>99.0%
Product Benefits
Weight loss
Anti-diabetes
Alzheimer's disease
Specification:5mg,10mg,1g,100g
Description
| Product Name: | 1H-Indole-2-carboxamide, 1-(cyanomethyl)-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-/ CAS 2212021-80-0 |
| Synonyms: | 1H-Indole-2-carboxamide, 1-(cyanomethyl)-N-methyl-N-phenyl-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-;(S)-1-(cyanomethyl)-5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-N-methyl-N-phenyl-1H-indole-2-carboxamide;5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-1-((1R,2R)-2-methyl-1-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)cyclopropyl)-1H-indole-2-carboxylic acid |
| CAS: | 2212021-80-0 |
| MF: | C25H27N3O2 |
| MW: | 401.5 |
Description Of Peptide
(LY3502970) (GLP-1 receptor agonist 1) is GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.
Function Of Peptide
Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.
--Leave us a message about the products you want.
--Description of order quantity.
--Please tell us your shipping address.
--The sales manager gives you a quote and sends you a contract.
If you have any product questions, you can consult us, our business E-mail: sales01@pharchemm.com.
If there is a quality problem with the product or it does not pass the test, you can rest assured that we have an after-sales guarantee .
Disclaimer:
All information provided on this website is for reference and study only, no medical advice, not for diagnosis, treatment of disease, Our company only provides intermediate powder for research use only.
Hot Tags: CAS 2212021-80-0, China, suppliers, manufacturers, factory, wholesale, buy, bulk, price, for sale, in stock, Lurasidone Intermediate, 4 6 Dichloro 4 methoxycarbonyl pyridazine, Tadanafil Intermediate, Ibrutinib N 3, Apixaban Intermediate, Pharmaceutical Peptide
Send Inquiry
You Might Also Like
